Screening for Osteoporosis to Prevent FracturesUS Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
JAMA. Published online January 14, 2025. doi:10.1001/jama.2024.27154
In this post – USPTF new guidance for osteoporosis screening @ יואל קסלר .קום we present the recently released guidance from USPTF on screening for osteoporosis to prevent fractures.
בפוסט זה הדרכה חדשה לבדיקת אוסטאופורוזיס @ יואל קסלר. קום אנו מציגים הנחיות חדשות למניעת שברים
Abstract
Importance Osteoporotic fractures are associated with psychological distress, subsequent fractures, loss of independence, reduced ability to perform activities of daily living, and death.
Objective The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the evidence on the benefits and harms of screening for osteoporosis to prevent fractures in adults 40 years or older with no known diagnosis of osteoporosis or history of fragility fracture.
Population Adults 40 years or older without known osteoporosis or history of fragility fractures.
Evidence Assessment The USPSTF concludes with moderate certainty that screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older has moderate net benefit. The USPSTF concludes with moderate certainty that screening for osteoporosis to prevent osteoporotic fractures in postmenopausal women younger than 65 years at increased risk has moderate net benefit. The USPSTF concludes that the evidence is insufficient and the balance of benefits and harms for screening for osteoporosis to prevent osteoporotic fractures in men cannot be determined.
Recommendation The USPSTF recommends screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older. (B recommendation) The USPSTF recommends screening for osteoporosis to prevent osteoporotic fractures in postmenopausal women younger than 65 years who are at increased risk for an osteoporotic fracture as estimated by clinical risk assessment. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men. (I statement)
See the Summary of Recommendations figure.
Pathway to Benefit
- To achieve the benefit of screening to reduce morbidity and mortality from fractures, women found to have osteoporosis should be further evaluated, counseled, and, if appropriate, receive evidence-based management.
The full guidance recommendations can be found here.
If you enjoyed this post – USPTF new guidance for osteoporosis screening @ יואל קסלר .קום check out more posts at out blog.
